Axalta Coating Systems Ltd. (AXTA) Stock Price & How to Invest

Axalta Coating Systems is a leading global manufacturer, marketer, and distributor of high-performance coatings, with more than 150 years of heritage in the industry. It runs two segments: Performance Coatings, which sells refinish coatings to auto-body shops and industrial coatings to a fragmented customer base, and Mobility Coatings, which supplies paint systems to light-vehicle and commercial-vehicle OEMs. The company operates roughly 47 manufacturing sites and serves customers in over 140 countries, with color-matching technology and refinish distribution as core competitive moats.

The defining feature of the investment picture is the all-stock merger of equals with AkzoNobel, announced in November 2025. Under the terms, Axalta holders receive 0.6539 AkzoNobel shares per Axalta share, ending up with about 45 percent of a combined company targeting roughly $600 million in synergies. The deal has moved forward through 2026: the SEC declared AkzoNobel's registration statement effective on June 23, Axalta called a special stockholder meeting for August 5 at which holders approved the merger, and on October 15 the companies announced the combined name Axanzo and the post-closing ticker AXZ. Axanzo will list on the NYSE and Euronext Amsterdam, with AkzoNobel CEO Greg Poux-Guillaume as CEO and Axalta CEO Chris Villavarayan as Deputy CEO, and will span about 100 brands in more than 160 countries. Closing is expected in early 2027, once regulatory approvals and customary conditions are finalized, and the two companies operate independently until then.

In the meantime AXTA behaves partly like a merger-arbitrage security whose value tracks the AkzoNobel exchange terms, while the underlying business remains a stable cash generator exposed to the automotive refinish and OEM cycle. Trailing twelve-month revenue is about $5.15 billion with net income near $349 million, and Q2 2026 adjusted EPS of $0.72 beat the roughly $0.65 consensus. Q3 2026 results are scheduled for October 29.

The single biggest risk is merger execution: remaining regulatory approvals and the AkzoNobel share price both affect the value Axalta holders ultimately receive, and a deal break would remove a key support for the stock. Because the exchange ratio is fixed, a fall in AkzoNobel shares or in the euro-dollar rate passes straight through to AXTA. The business is cyclical, with Mobility volumes tied to auto and commercial-vehicle production and industrial coatings tied to construction and manufacturing activity. Raw-material and energy cost inflation can compress margins faster than pricing catches up. Axalta carries meaningful debt (roughly $3.1 billion against about $634 million of cash), and integration of two large organizations always risks synergy shortfalls, dis-synergies, and management distraction. Foreign-exchange swings also matter given the global footprint.

17 analysts publish price targets on AXTA, averaging $39.18 against a $33.44 price as of October 2026, or +17.2%. The published targets run from $33.00 to $47.00, a moderate spread, and the ratings split 8 buy, 10 hold, 0 sell. Over the last six months there have been 5 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full AXTA forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Axalta Coating Systems Ltd.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. AkzoNobel merger of equals (Axanzo). The pending all-stock combination with AkzoNobel is the dominant driver, with a fixed 0.6539 exchange ratio and Axalta holders owning about 45 percent of the combined company. The most optimistic published target, $47.00, assumes this works close to its best case.

The case against. The single biggest risk is merger execution: remaining regulatory approvals and the AkzoNobel share price both affect the value Axalta holders ultimately receive, and a deal break would remove a key support for the stock. The most pessimistic target, $33.00, is roughly what AXTA is worth if this bites instead.

Read the full bull and bear case on AXTA, including what would have to change to break either one. Walnut is not an investment adviser.

No. Axalta Coating Systems Ltd. (AXTA) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Axalta Coating Systems Ltd.'s investor relations page or your broker.

• Market cap: ~$7.2B
• Revenue (TTM): ~$5.15B (+3% YoY in Q2)
• Q2 2026 net sales: ~$1.35B
• Operating / net margin: ~15% / ~7%
• Net income (TTM): ~$349M
• P/E (TTM / forward): ~20.7x / ~11.8x
• EV / EBITDA: ~9.8x
• Dividend: None

Axalta trades at about 21 times trailing GAAP earnings but under 12 times forward earnings and about 9.8x EV/EBITDA, a valuation typical of a mature, cash-generative specialty-chemicals name. Q2 2026 net sales of about $1.35 billion rose about 3 percent year over year and adjusted EPS of $0.72 beat the $0.65 estimate; Q3 results are due October 29, 2026, with consensus EPS near $0.70. With the Axanzo merger pending, the market increasingly prices AXTA against the 0.6539 exchange ratio and the combined company's outlook rather than standalone multiples alone.

Other names that sit close to AXTA: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get AXTA exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so AXTA sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where AXTA fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

AXTA is a steady, cash-generative coatings leader whose near-term returns are tied to the pending AkzoNobel merger (Axanzo, expected to close in early 2027) and to a cyclical auto and industrial demand backdrop. Each Axalta share is set to become 0.6539 AkzoNobel shares, so the AkzoNobel share price now drives most of AXTA's value.

Whether AXTA is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is AXTA a buy or a sell?, and where the stock could go from here in the AXTA stock forecast.

For income investors, whether AXTA pays a dividend and how the payout looks is covered in does AXTA pay a dividend? And to weigh AXTA against a peer, read the full side-by-side comparisons: AXTA vs PPG and AXTA vs SHW.